摘要
目的探讨2012—2016年中国大陆生物医学领域高质量科技论文的分布状况。方法以Web of Science和CSCD所收录文献为数据源，首先统计分析中国大陆生物医学中英文论文的数量及增长率变化状况，然后进一步分析论文的研究方向分布、基金资助分布及SCI论文的期刊分布情况。结果中国大陆生物医学论文逐年增多，SCI论文所占比例从2012年的34.03%，上升到2016年的55.65%，表现尤为明显。SCI论文发文最多的是肿瘤学，CSCD论文发文最多的是普通内科。国家自然科学基金资助的论文在基金资助论文中位于第一位。科研人员的论文研究方向更偏向基础医学研究，但多数SCI论文影响力有待提高。结论中国大陆生物医学科技论文产出量逐年增多，国内优秀论文稿源大量流失。国家及科研管理部门应坚持正确的政策导向，加大对国内期刊的支持力度；鼓励和引导医学科研人员发表更多高质量临床研究论文。
ObjectiveDiscussing the distribution of the biomedical top papers of China Mainland from 2012 to 2016.MethodsAnalyzing the quantity and growth rate of China Mainland’s biomedical papers, as well as the research direction distribution, fund distribution and journal distribution of SCI papers, which based on Web of Science database and CSCD database.ResultsThe biomedical papers of China Mainland increased year by year, particularly the SCI papers. The proportion of SCI papers rising to 55.65% from 34.03% during 2012-2016.The subject which has the most SCI papers is oncology, but the most CSCD papers is general internal medicine. The NSFC funded the largest number SCI papers and CSCD papers. Most scientific papers which growing faster is belong to basic medicine, but they are not outstanding.ConclusionsThe biomedical papers of China Mainland increased year by year, but a large number of domestic excellent papers run off. Our country and the scientific research management departments should insist the policy guidance, and strengthen the support to the domestic journals; Encouraging and guiding the medical staff to publish more high quality clinical research papers.
作者
李向森
杨华
Li Xiangsen;Yang Hua(Library of Shengjing Hospital,China Medical University,Shenyang 110004,Liaoning Province,P.R.China)
出处
《中华医学科研管理杂志》
2018年第5期365-369,共5页
Chinese Journal of Medical Science Research Management
